
SynBioBeta Speaker
Connor Tsuchida
Scientific Co-founder, VP, R&D
Azalea Therapeutics
May 2026, SynBioBeta
Speaker
Connor Tsuchida is a Scientific Co-Founder and the Vice President, Research & Development at Azalea Therapeutics, a biotechnology company pioneering in vivo genome editing therapies with cell and genomic precision. He earned his PhD in Bioengineering from UC Berkeley and UCSF, where he trained under Nobel Laureate Jennifer Doudna. His doctoral research focused on developing novel technologies to enhance the efficacy and safety of CRISPR-Cas genome editing in T cells -- work that was foundational to the founding of Azalea Therapeutics. Connor has been recognized by Forbes 30 under 30, the San Francisco Business Times 40 under 40, and the Seibel Scholarship for Bioengineers.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include

Join for the latest
SynBioBeta event updates.








































































































































































































































































































































































































































